Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
What's New at TheBody.com
  
  • Email Email
  • Glossary Glossary

 

Long-Term AIDS Survivors Gather in San Francisco, With Vision of National Network of Elders, Teachers and Leaders

Sue Saltmarsh, TheBody.com; Posted Oct 1, 2:43 p.m. ET

Let's Kick Ass (LKA) holds second annual town meeting, and aspires to more support and services for survivors, education and outreach activities and a political and policy agenda.

Cure Research at IAS 2014: TILDA Measures the Reservoir and Romidepsin Wakes It Up

Simon Collins, HIV i-Base; Posted Oct 1, 2:27 p.m. ET

Cure-related research was one of the leading medical and scientific issues at AIDS 2014, adding new pieces to a puzzle that leading researchers believe is likely to take at least a decade to solve.

Open-Label Oral PrEP at 4 Doses a Week: Why Zero Infections Does Not Equal 100% Efficacy

Simon Collins, HIV i-Base; Posted Oct 1, 2:26 p.m. ET

One of the most important advances at AIDS 2014 was a late-breaker study on open label use of oral PrEP, presented by Robert Grant from UCSF.

Kaiser Survey Offers Comprehensive Look at Gay Men's Attitudes and Behaviors Regarding HIV

Josh Kruger, TheBody.com; Posted Sep 30, 11:27 p.m. ET

How often do gay men get tested? How many people living with HIV do they know? Age and race and many other factors influence the answers to these questions, which a new Kaiser survey explores.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?


Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?

 

No Difference in Overall Anemia Rate With Reduced-Dose AZT

Polly Clayden, HIV i-Base; Posted Sep 30, 2:00 p.m. ET

A study looking at reduced-dose AZT showed no difference in overall rate of anaemia but demonstrated improved safety and similar efficacy compared to standard dose.

Pill A, Pill B: Simplified Second-Line Treatment for Low-Income Countries

Polly Clayden, HIV i-Base; Posted Sep 30, 1:59 p.m. ET

A one pill, once-daily fixed dose combination (FDC) second-line regimen might be feasible for low-income countries according to a clinical development programme presented at AIDS 2014.

Checking Back in After My Long Hospitalizations

Lynda Arnold, TheBody.com; Posted Sep 30, 12:27 p.m. ET

"I realized that we only get one life -- one pass through -- and God, it has to count." Blogger Lynda Arnold shares lessons from a long, frightening period of health challenges.

Why I Refused, Then Later Embraced, HIV Treatment

Josh Kruger, TheBody.com; Posted Sep 29, 6:18 p.m. ET

For Josh Kruger, fear was a big factor in his decision to delay treatment. Does fear play a part in your HIV med adherence?

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.

 

New FDA HIV Drug Approvals Unlikely to Have Much Impact, Unless ...

Paul E. Sax, M.D., Journal Watch; Posted Sep 29, 5:38 p.m. ET

"If you're wondering what the big deal is [about the approvals of stand-alone cobicistat and elvitegravir], welcome to the club," Paul Sax, M.D., writes.

The Miracles That Come After an HIV Diagnosis

Erin Wanjira, TheBody.com; Posted Sep 29, 4:52 p.m. ET

In the midst of depression and a violent relationship, Erin was diagnosed with HIV and found her way out.

Higher ART Coverage Is Associated With Lower HIV Infection Rates in a Multi-Country Analysis

Polly Clayden, HIV i-Base; Posted Sep 29, 2:41 p.m. ET

If all low- and middle-income countries had achieved the same level of antiretroviral treatment (ART) coverage as Botswana in 2012, 65% of new HIV infections and 70% of HIV-related deaths could have been prevented -- according to an analysis presented at AIDS 2014.

The Loss of Friends and Colleagues From Flight MH17

Polly Clayden and Simon Collins, HIV i-Base; Posted Sep 29, 2:38 p.m. ET

Like so many people at the AIDS 2014 conference and beyond we [at HIV i-Base] were jolted with sadness when we heard the appalling news of the six delegates who were killed on flight MH 17.


>> Browse Older Featured Stories

 


  
  • Email Email
  • Glossary Glossary
Advertisement